Adrenomedullary function during cognitive testing in attention- deficit/hyperactivity disorder

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 39, Issue 5, 2000, Pages 635-643

  Anderson, George M ^a,e   Dover, Marcia A ^b   Yang, Benson P ^c   Holahan, John M ^b   Shaywitz, Sally E ^b   Marchione, Karen E ^b   Hall, Laura M ^a   Fletcher, Jack M ^d   Shaywitz, Bennett A ^b  

^a Department of Pediatrics   (United States)

^b Department of Pediatrics ^*

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Attention deficit hyperactivity disorder; Epinephrine; Inattention

Indexed keywords

ADRENALIN; NORADRENALIN;

ADOLESCENT; ADRENAL MEDULLA; ADRENERGIC SYSTEM; ARTICLE; ATTENTION DEFICIT DISORDER; CATECHOLAMINE EXCRETION; CHILD; COGNITION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SCHOOL CHILD; URINARY EXCRETION;

EID: 0034094351     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200005000-00018     Document Type: Article

References (54)

1. Agronin M, Shaywitz SE, Holahan JM, Shaywitz BA (1992), Yale Multigrade Inventory for Teachers (MIT): scale development and psychometric properties. In: Attention Deficit Disorder Comes of Age: Toward the 21st Century, Shaywitz SE, Shaywitz BA, eds. Austin, TX: Pro-Ed, pp 89-116
2. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association
3. Anderson GM, Durkin TA, Morton JB, Cohen DJ (1988), Liquid Chromatographic determination of urinary catecholamines after one-step alumina extraction. J Chromatogr 424:373-377
4. Arnsten AFT (1997), Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 11:151-162
5. Arnsten AFT, Steere JC, Hunt RD (1996), The contribution of alpha-2 noradrenergic mechanisms to prefrontal cortical cognitive functions: potential significance to attention deficit hyperactivity disorder. Arch Gen Psychiatry 53:448-455
6. Aston-Jones G, Chiang C, Alexinsky T (1991), Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog Brain Res 88:501-520
7. Barkley RA, DuPaul GJ, McMurray MB (1990), Comprehensive evaluation of attention deficit disorder with and without hyperactivity as defined by research criteria. J Consult Clin Psychol 58:775-789
8. Bradley C (1937), The behavior of children receiving benzedrine. Am J Psychiatry 94:577-585
9. Chappell PB, Riddle MA, Scahill L et al. (1995), Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 34:1140-1146
10. Cohen P, Cohen J (1984), The clinician's illusion. Arch Gen Psychiatry 41:1178-1182
11. Cyr M, Brown CS (1998), Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder. Drugs 56:215-223
12. Donnelly M, Rapport JI, Potter WZ, Oliver J, Keysor CS, Murphy DL (1989), Fenfluramine and dextroamphetamine treatment of childhood hyperactivity: clinical and biochemical findings. Arch Gen Psychiatry 46:205-212
13. Edwards AV, Jones CT (1993), Autonomic control of adrenal function. J Anat 183:291-307
14. Elia J, Borcherding BG, Potter WZ, Mefford IN, Rapoport JL, Keysor CS (1990), Stimulant drug treatment of hyperactivity: biochemical correlates. Clin Pharmacol Ther 48:57-66
15. Elwood SW, Ferguson HB, Thakar J (1986), Catecholamine response of children in a naturally occurring stressor situation. J Hum Stress 12:154-161
16. Ernst M, Zametkin A (1995), The interface of genetics, neuroimaging, and neurochemistry in attention-deficit hyperactivity disorder. In: Psychopharmacology: The Fourth Generation of Progress, Bloom FE, Kupfer DJ, eds. New York Raven Press, pp 1643-1652
17. Frankenhaeuser M (1971), Behavior and circulating catecholamines. Brain Res 31:241-262
18. Frankenhaeuser M, Jarpe G (1963), Psychophysiological changes during infusions of adrenaline in various doses. Psychopharmacologia 4:424-432
19. Girardi ML, Shaywitz SE, Shaywitz BA et al. (1995), Blunted catecholamine responses after glucose ingestion in children with attention deficit disorder. Pediatr Res 38:539-542
20. Halperin JM, Newcorn JH, Koda VH, Pick L, McKay KE, Knott P (1997), Noradrenergic mechanisms in ADHD children with and without reading disabilities: a replication and extension. J Am Acad Child Adolesc Psychiatry 36:1688-1697
21. Hanna GL, Ornitz EM, Hariharan M (1996), Urinary epinephrine excretion during intelligence testing in attention-deficit hyperactivity disorder and normal boys. Biol Psychiatry 40:553-555
22. Hastings JE, Barkley RA (1978), A review of psychophysiological research with hyperkinetic children. J Abnorm Child Psychol 6:413-447
23. Hunt RD, Arnsten AF, Asbell MD (1995), An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:50-54
24. Hunt RD, Cohen DJ, Anderson GM, Clark L (1984), Possible change in noradrenergic receptor sensitivity following methylphenidate treatment: growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder. Life Sci 35:885-897
25. Introini-Collison I, Saghafi D, Novack GD, McGaugh JL (1992), Memory-enhancing effects of post-training dipivefrin and epinephrine: involvement of peripheral and central adrenergic receptors. Brain Res 572:81-86
26. Johansson G, Frankenhaeuser M, Magnussen D (1973), Catecholamine output in school children as related to performance and adjustment. Scand J Psychol 14:20-28
27. Lahey BB, Applegate B, McBurnett K et al. (1994), DSM-IV field trials for attention-deficit/hyperactivity disorder in children and adolescents. Am J Psychiatry 151:1673-1685
28. Lambert WW, Johansson G, Frankenhaeuser M, Klackenberg-Larsson I (1969), Catecholamine excretion in young children and their parents as related to behavior. Scand J Psychol 10:306-318
29. McCracken JT (1991), A two-part model of stimulant action on attention-deficit hyperactivity disorder in children. J Neuropsychiatry Clin Neurosci 3:201-209
30. McMahon RC (1984), Hyperactivity as dysfunction of activity, arousal, or attention: a study of research relating to DSM-III's attention deficit disorder. J Clin Psychol 40:1300-1308
31. Mefford IN, Potter WZ (1989), A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: a defect in tonic adrenaline mediated inhibition of locus cocruleus stimulation. Med Hypotheses 29:33-42
32. Mikkelsen E, Lake CR, Brown GL, Ziegler MG, Ebert MH (1981), The hyperactive child syndrome: peripheral sympadietic nervous system function and the effect of d-amphetamine. Psychiatry Res 4:157-169
33. Moleman P, Tulen JH, Blankestijn PJ, Man in't Veld AJ, Boomsma F (1992), Urinary excretion of catecholamines and their metabolites in relation to circulating catecholamines. Arch Gen Psychiatry 49:568-572
34. Oades RD (1987), Attention deficit disorder with hyperactivity (ADDH): the contribution of catecholaminergic activity. Prog Neurobiol 29:365-391
35. Ornitz EM, Gabikian P, Russel AT, Guthrie D, Hirano C, Gehricke JG (1997), Affective valence and arousal in ADHD and normal boys during a startle habituation experiment. J Am Acad Child Adolesc Psychiatry 36:1698-1705
36. Pliszka SR, Maas JW, Javors MA, Rogeness GA, Baker J (1994), Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 33:1165-1173
37. Pliszka SR, McCracken JT, Maas JW (1996), Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 35:264-272
38. Rapoport JL, Lott IT, Alexander DF, Abramson AU (1970), Urinary noradrenaline and playroom behaviour in hyperactive boys. Lancet 2:1141
39. Rapoport JL, Mikkelsen EJ, Ebert MH, Brown GL, Weise V, Kopin IJ (1978), Urinary catecholaminergic and amphetamine excretion in hyperactive and normal boys. J Nerv Ment Dis 166:731-737
40. Raskin LA, Shaywitz SE, Shaywitz BA, Anderson GM, Cohen DJ (1984), Neurochemical correlates of attention deficit disorder. Pediatr Clin North Am 31:387-396
41. Rogeness GA, Maas JW, Javors MA, Macedo CA, Fischer C, Harris WR (1989), Attention deficit disorder symptoms and urine catecholamines. Psychiatry Res 27:241-251
42. Roozendaal B, Carmi O, McGaugh JL (1996), Adrenocortical suppression blocks the memory-enhancing effects of amphetamine and epinephrine. Proc Natl Acad Sci USA 93:1429-1433
43. Rowe D, Stever C, Giedinghagen L et al. (1998), Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry 3:419-426
44. Satterfield HJ, Cantwell PD, Satterfield TB (1974), Pathophysiology of the hyperactive child syndrome. Arch Gen Psychiatry 31:839-844
45. Shaffer D, Fisher P, Dulcan MK et al. (1996), The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA study. J Am Acad Child Adolesc Psychiatry 35:865-877
46. Shekim WO, Dekermenjian H, Chapel JL, Javaid J, Davis JM (1979), Norepinephrine metabolism and clinical response to d-amphetamine in hyperactive boys. J Pediatr 95:389-394
47. Snyder SH, Meyerhoff JL (1973), How amphetamine works in minimal brain dysfunction. Ann N Y Acad Sci 205:310-320
48. Swartz CM, Drews V, Cadoret R (1987), Decreased epinephrine in familial alcoholism. Arch Gen Psychiatry 44:938-941
49. Tennes K, Kreye M, Avitable N, Wells R (1986), Behavioral correlates of excreted catecholamines and cortisol in second-grade children. J Am Acad Child Psychiatry 25:764-770
50. von Euler US (1964), Quantitation of stress by catecholamine analysis. Clin Pharmacol Ther 5:398-409
51. Waldman I, Rowe D, Abramowitz A et al. (1998), Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 63:1767-1776
52. Wechsler D (1974), Manual for the Wechsler Intelligence Scale for Children, Revised. New York: Harcourt, Brace, Jovanovitch
53. Williams CL, McGaugh JL (1993), Reversible lesions of the nucleus of the solitary tract attenuate the memory-modulating effects of posttraining epinephrine. Behav Neurosci 107:955-962
54. Zametkin AJ, Rapoport JL (1987), Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years? J Am Acad Child Adolesc Psychiatry 26:676-686